Clinical trial
Effectiveness of a Mind-Body Reprogramming Therapy vs. Care as Usual for Adolescents Aged 12-18 With Chronic Fatigue: A Randomized Controlled Trial.
NCT07923539 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of a Mind-Body Reprogramming Therapy vs. Care as Usual for Adolescents Aged 12-18 With Chronic Fatigue: A Randomized Controlled Trial.
- Lead sponsor
- Oslo University Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- November 9, 2026
- Completion date
- September 30, 2028
- Enrollment
- 210 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
chronic fatigue
Arms
As registered; 2 arms.
-
Care as Usual
These patients receive the standard treatment provided to this patient group at the respective study site.
-
Mind-Body Reprogramming Therapy
These patients receive Mind-Body Reprogramming Therapy (MBRT), as described in the attached protocol
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Chalder Fatigue Questionnare (CFQ)
Total score on the CFQ, 0-33
Lead sponsor's other trials
Oslo University Hospital, most recent start first.
+828 more trials See the organization page